Peptides
P-21 and P021: promising mouse work is not a human treatment
Research on the compound P021 reports cognitive effects in mouse models, but the catalog’s P-21 label does not prove chemical identity or any human benefit.
Keep learning. Keep adapting.
Research notes and practical guides on supplements, nutrition, exercise, and the questions behind better training.
Explore the research
71 articlesPeptides
Oxytocin: what social and sexual-health trials show
Oxytocin affects social and reproductive physiology, but intranasal trials show mixed behavioral results. Those studies do not establish a dose for a 10 mg research vial.
Peptides
NA-Semax amidate: modified peptide, untested claims
NA-Semax amidate is a chemically modified Semax analogue. Parent Semax studies cannot establish its claimed focus, memory, or recovery benefits.
Peptides
NA-Selank amidate: a modified calm peptide without clinical trials
This N-acetylated, amidated Selank analogue is promoted for calm and anxiety support, but studies of ordinary Selank do not test the modified product.
Peptides
NA-Epithalon: why the modified form needs its own evidence
NA-Epithalon is sold as a modified Epithalon product. Claims about telomeres and longevity come mainly from other materials and laboratory studies, not clinical testing of this exact form.
Peptides
LL-37: antimicrobial biology and the wound-healing trials
LL-37 is a human antimicrobial peptide. A 148-person topical wound trial did not improve healing overall; its topical concentrations do not support injectable use.
Peptides
KLOW: what is known about the four-peptide blend
KLOW combines GHK-Cu, BPC-157, TB-500, and KPV. The four ingredients have separate research histories, but the exact blend has no controlled human efficacy or dosing study.
Peptides
Kisspeptin: reproductive hormones and the limits of current evidence
Specific kisspeptin forms have altered reproductive hormones in small human trials, but a catalog vial labeled only “kisspeptin” cannot inherit those findings or doses.
Peptides
IGF-1 LR3: what the research actually shows
IGF-1 LR3 is a modified growth factor studied mainly in animals. Its muscle-growth claims have not been confirmed in human trials, and no safe adult dose is established.
Peptides
Glutathione: skin claims, route differences, and injection safety
Glutathione is an important antioxidant, but oral skin studies do not establish the benefits or safety of a research-market injectable vial.
Peptides
GLOW peptide blend: claims, evidence, and dose context
GLOW combines GHK-Cu, BPC-157, and TB-500; the ingredients have separate research records, but the blend has no controlled human efficacy trial.
Peptides
CORE45 (TB4 + BPC-157 + KPV): evidence for the blend
Each ingredient has a different research record; the three-peptide CORE45 blend has no established human healing benefit or dose.
Peptides
CJC-1295 with DAC: hormone results versus fitness claims
Human studies found sustained growth-hormone and IGF-1 increases, but did not establish muscle, fat-loss, or anti-aging benefits.
Peptides
CJC no DAC + Ipamorelin: mechanism, claims, and evidence gaps
The blend targets two growth-hormone signaling pathways, but its fitness outcomes and safety have not been established in controlled human trials.
Peptides
Cerebrolysin: clinical research and the supplier-label problem
Cerebrolysin trials used a defined liquid peptide mixture; a supplier’s 30 mg vial without a certificate of analysis cannot be assumed equivalent.
Peptides
Cagrilintide for weight loss: what the trials actually show
Cagrilintide has meaningful weight-loss trial results, but the studied drug and a catalog vial are not interchangeable.
Peptides
ARA-290 (cibinetide): what nerve-pain trials found
A look at the small human trials of ARA-290 for small-fiber neuropathy, their measured outcomes, and the limits of a research vial.
Peptides
AHK-Cu for hair: promising lab signal, unproven clinical benefit
What an ex vivo hair-follicle study actually found about AHK-Cu and where scalp-use claims outrun the evidence.
Peptides
Adamax: what is known about this Semax-related peptide?
Adamax is marketed for focus, but its exact formulation, human effects, and safe dose have not been established.
Peptides
Abaloparatide: bone-building evidence and the catalog-vial gap
What the osteoporosis trials show for prescription abaloparatide, how it works, and why those results do not validate a research vial.
Peptides
Selank
Selank research on anxiety and calm, including small clinical studies, proposed brain pathways, and the limits of everyday stress use.
Peptides
Semax
Semax research on attention, memory, brain signaling, and the difference between early human findings and a dependable focus benefit.
Peptides
MOTS-c
MOTS-c is a mitochondrial peptide studied for metabolism and physical performance. Animal findings are promising; human exercise research and treatment trials need careful distinction.
Peptides
DSIP
DSIP is studied for sleep regulation. Small human trials have produced mixed findings, and its name does not establish a reliable deep-sleep benefit.